200 related articles for article (PubMed ID: 21897392)
1. Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer.
Kaneda H; Arao T; Matsumoto K; De Velasco MA; Tamura D; Aomatsu K; Kudo K; Sakai K; Nagai T; Fujita Y; Tanaka K; Yanagihara K; Yamada Y; Okamoto I; Nakagawa K; Nishio K
Br J Cancer; 2011 Oct; 105(8):1210-7. PubMed ID: 21897392
[TBL] [Abstract][Full Text] [Related]
2. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
[TBL] [Abstract][Full Text] [Related]
3. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.
Panopoulou E; Murphy C; Rasmussen H; Bagli E; Rofstad EK; Fotsis T
Cancer Res; 2005 Mar; 65(5):1877-86. PubMed ID: 15753386
[TBL] [Abstract][Full Text] [Related]
4. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma.
Ervolino De Oliveira C; Dourado MR; Sawazaki-Calone Í; Costa De Medeiros M; Rossa Júnior C; De Karla Cervigne N; Esquiche León J; Lambert D; Salo T; Graner E; Coletta RD
Int J Oncol; 2020 Jul; 57(1):364-376. PubMed ID: 32377747
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of cell growth by activin in SNU-16 cells.
Kim YI; Lee HJ; Khang I; Cho BN; Lee HK
World J Gastroenterol; 2006 May; 12(19):3000-5. PubMed ID: 16718778
[TBL] [Abstract][Full Text] [Related]
6. Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells.
Wagner K; Peters M; Scholz A; Benckert C; Ruderisch HS; Wiedenmann B; Rosewicz S
Gastroenterology; 2004 Jun; 126(7):1828-43. PubMed ID: 15188178
[TBL] [Abstract][Full Text] [Related]
7. Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells.
Burdette JE; Jeruss JS; Kurley SJ; Lee EJ; Woodruff TK
Cancer Res; 2005 Sep; 65(17):7968-75. PubMed ID: 16140969
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.
Gong Z; Ma J; Su H; Guo T; Cai H; Chen Q; Zhao X; Qi J; Du J
Int J Clin Oncol; 2018 Aug; 23(4):659-670. PubMed ID: 29344744
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells.
Li Y; Li D; Zhao M; Huang S; Zhang Q; Lin H; Wang W; Li K; Li Z; Huang W; Che Y; Huang C
Life Sci; 2018 Sep; 208():295-304. PubMed ID: 30031062
[TBL] [Abstract][Full Text] [Related]
10. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
Yasutome M; Gunn J; Korc M
Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
[TBL] [Abstract][Full Text] [Related]
11. JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer.
Chen Y; Huang Y; Huang Y; Xia X; Zhang J; Zhou Y; Tan Y; He S; Qiang F; Li A; Re OD; Li G; Zhou J
Carcinogenesis; 2014 Feb; 35(2):442-51. PubMed ID: 24072772
[TBL] [Abstract][Full Text] [Related]
12. FP3: a novel VEGF blocker with antiangiogenic effects in vitro and antitumour effects in vivo.
Jin K; He K; Teng F; Li G; Wang H; Han N; Xu Z; Cao J; Wu J; Yu D; Teng L
Clin Transl Oncol; 2011 Dec; 13(12):878-84. PubMed ID: 22126731
[TBL] [Abstract][Full Text] [Related]
13. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
Pardali K; Kowanetz M; Heldin CH; Moustakas A
J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
[TBL] [Abstract][Full Text] [Related]
14. Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression.
Poulaki V; Mitsiades N; Kruse FE; Radetzky S; Iliaki E; Kirchhof B; Joussen AM
Am J Pathol; 2004 Apr; 164(4):1293-302. PubMed ID: 15039217
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer.
Togashi Y; Sakamoto H; Hayashi H; Terashima M; de Velasco MA; Fujita Y; Kodera Y; Sakai K; Tomida S; Kitano M; Ito A; Kudo M; Nishio K
Mol Cancer; 2014 May; 13():126. PubMed ID: 24886203
[TBL] [Abstract][Full Text] [Related]
16. Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis.
Li T; Liu X; Shen Q; Yang W; Huo Z; Liu Q; Jiao H; Chen J
Oncotarget; 2016 May; 7(18):26580-92. PubMed ID: 27058891
[TBL] [Abstract][Full Text] [Related]
17. Gastrin promotes angiogenesis by activating HIF-1α/β-catenin/VEGF signaling in gastric cancer.
Tang E; Wang Y; Liu T; Yan B
Gene; 2019 Jul; 704():42-48. PubMed ID: 30980943
[TBL] [Abstract][Full Text] [Related]
18. A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth.
Colin S; Guilmain W; Creoff E; Schneider C; Steverlynck C; Bongaerts M; Legrand E; Vannier JP; Muraine M; Vasse M; Al-Mahmood S
Br J Cancer; 2011 Sep; 105(7):1002-11. PubMed ID: 21863033
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1.
Fu YG; Sung JJ; Wu KC; Bai AH; Chan MC; Yu J; Fan DM; Leung WK
Cancer Lett; 2006 Nov; 243(2):246-54. PubMed ID: 16412567
[TBL] [Abstract][Full Text] [Related]
20. MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway.
Wang L; Zhou R; Zhao Y; Dong S; Zhang J; Luo Y; Huang N; Shi M; Bin J; Liao Y; Liao W
PLoS One; 2016; 11(6):e0157137. PubMed ID: 27280289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
